Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

16.48
+0.07000.43%
Volume:110.17K
Turnover:1.81M
Market Cap:731.38M
PE:-7.35
High:16.94
Open:16.01
Low:16.01
Close:16.41
52wk High:24.00
52wk Low:2.88
Shares:44.38M
Float Shares:28.58M
Volume Ratio:0.46
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2432
EPS(LYR):-2.2432
ROE:-27.09%
ROA:-17.76%
PB:2.69
PE(LYR):-7.35

Loading ...

BioAge Labs price target raised to $52 from $15 at Citi

TIPRANKS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

BioAge Labs Chief Medical Officer Paul D Rubin Disposes of Common Shares

Reuters
·
Mar 04

U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP

Reuters
·
Feb 25

Bioage Labs Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $60

THOMSON REUTERS
·
Feb 25

BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
Feb 20

BioAge Labs Raised to Buy From Hold by Jefferies

Dow Jones
·
Feb 18

Bioage Labs Inc : Jefferies Raises to Buy From Hold; Raises Target Price to $62 From $9

THOMSON REUTERS
·
Feb 18

BioAge Labs upgraded to Buy from Hold at Jefferies

TIPRANKS
·
Feb 18

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Ansell (OtherANSLF)

TIPRANKS
·
Feb 16

Morgan Stanley Boosts Price Target on BioAge Labs to $23 From $12, Keeps Equalweight Rating

MT Newswires Live
·
Feb 04

BioAge Labs Initiated at Overweight by Piper Sandler

Dow Jones
·
Jan 27

BioAge Labs initiated with an Overweight at Piper Sandler

TIPRANKS
·
Jan 27

BioAge Labs: De-Risked NLRP3 Program and 2026 Clinical Catalysts Underpin Overweight/Buy Rating

TIPRANKS
·
Jan 27

U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings

Reuters
·
Jan 27

Bioage Labs Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $73

THOMSON REUTERS
·
Jan 27

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel

Reuters
·
Jan 23

BUZZ-U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital

Reuters
·
Jan 22

BUZZ-BioAge Labs edges down after stock sale hiked to $115 mln

Reuters
·
Jan 22

BRIEF-Bioage Announces Pricing Of Upsized $115 Million Public Offering

Reuters
·
Jan 22